CareNostics is an unclaimed profile.
If you work at Carenostics, sign up or log in to claim the profile today.
Carenostics
CareNostics
Carenostics offers AI-powered clinical decision support tools designed to enhance the management of chronic diseases like diabetes, hypertension, and chronic kidney disease. Their solutions integrate with EHRs to analyze patient data, providing early identification and actionable insights to healthcare providers.
Product Overview
Security and Compliance Certifications: HIPAA
Carenostics offers AI-powered clinical decision support tools designed to enhance the management of chronic diseases like diabetes, hypertension, and chronic kidney disease. Their solutions integrate with EHRs to analyze patient data, providing early identification and actionable insights to healthcare providers. This helps in better disease management, personalized care, and reducing hospital admissions.
Customers Served
Categories
Company Info
HQ Location
Philadelphia, Pennsylvania
Founded
2021
Headcount
1-10
Total Funding
$5M
Latest Round
Seed
Latest Round
09/13/2023
Company Socials
Demos
Customers
4
Verified customers
Type
0
1
2
3
Hospitals / Health System (3)
Provider Headcount
0
1
2
3
5001+ (3)
Showcased Customers
See all (4)Azra AI
Claimed
Azra AI
Company Info
Founded: 2022
Headcount: 11-50
Customers
Verified Customers: 3
Customers Served: Hospital / Health System, Health Plan
Product Overview
Security and Compliance Certifications: HITRUST CSF, HIPAA
Azra AI develops AI-powered solutions aimed at optimizing clinical workflows in healthcare, particularly in oncology and radiology. Their technology is used to automate the identification and prioritization of cancer patients from pathology reports, manage incidental findings in radiology, and streamline tumor registry processes. By integrating with existing healthcare systems, Azra AI's tools help healthcare providers deliver timely and efficient care, reduce workflow inefficiencies, and ensure compliance with regulatory standards.
Other Categories
C the Signs
C the Signs
Company Info
Founded: 2017
Headcount: 51-200
Customers
Customers Served: Hospital / Health System
Product Overview
C the Signs is a clinical decision support tool designed to help healthcare professionals identify cancer risk at an early stage. It uses artificial intelligence and evidence-based guidelines to assess patient symptoms, risk factors, and clinical data, providing recommendations for appropriate investigations and referrals. The platform is intended for use in primary care and other healthcare settings to improve early cancer detection and streamline the referral process.
Other Categories
Creyos
Creyos
Company Info
Founded: 2014
Headcount: 51-200
Customers
Verified Customers: 3
Customers Served: Hospital / Health System
Product Overview
Security and Compliance Certifications: HIPAA, SOC 2 Type 2
Creyos is a digital cognitive and behavioral health assessment platform designed for clinicians and researchers to evaluate brain function across key domains like memory, attention, and executive function. The platform offers scientifically validated online tasks and questionnaires developed from over 30 years of neuroscience research and supported by more than 400 peer-reviewed studies. Creyos enables early detection of conditions such as ADHD, mild cognitive impairment (MCI), and dementia, providing clear, domain-specific reports for clinical decision-making.
Other Categories